Emmanouela Petsolari

Emmanouela Petsolari is the Co-Founder and CEO of ACX, a biotechnology startup based in the United Kingdom. She recently completed her doctoral studies, earning a PhD in Biochemistry and Biophysics from the University of Cambridge spanning from 2020 to 2024. Prior to founding ACX, Petsolari built a specialized scientific foundation through research roles at several premier European institutions, including Imperial College London, King’s College London, and Institut Curie in France. Her academic career focused on diverse life sciences applications, encompassing immunology, oncology, malaria vaccine development, and viral drug discovery. She also conducted specialized cancer research at the Barts Cancer Institute, part of Cancer Research UK, contributing to her expertise in molecular biology and biophysics. Petsolari currently focuses on leveraging her extensive academic research background to drive advanced scientific applications and commercial biotechnology product development at ACX.